This article has been cited by
1Macitentan in daily clinical practice: A single centre, 1-year experience
S. Cadenas-Menéndez,P. Álvarez-Vega,J. Martín-Moreiras,M. Barreiro-Pérez,M.Á. Gómez-Sánchez,P.L. Sánchez-Fernández
Pulmonology.2018;24(3)170
[DOI]
2Pulmonary arterial hypertension outcomes upon endothelin-1 receptor antagonist switch to macitentan
Timothy Tynan,Kathryn Hird,Tara Hannon,Eli Gabbay
Journal of International Medical Research.2019;47(5)2177
[DOI]
3Bosentan or Macitentan Therapy in Chronic Thromboembolic Pulmonary Hypertension?
M. C. J. van Thor,L. ten Klooster,R. J. Snijder,J. C. Kelder,J. J. Mager,M. C. Post
Lung.2019;197(6)753
[DOI]
4A Focus on Macitentan in the Treatment of Pulmonary Arterial Hypertension
Martin Bedan,Daniela Grimm,Markus Wehland,Ulf Simonsen,Manfred Infanger,Marcus Krüger
Basic & Clinical Pharmacology & Toxicology.2018;123(2)103
[DOI]
5New Tactics for the Treatment of Pulmonary Hypertension: Switching to a More Effective Therapy
N. A. Tsareva,S. N. Avdeev
Kardiologiia.2018;58(12)93
[DOI]
6A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment
Robert S. Kerbel
The Cancer Journal.2015;21(4)274
[DOI]
7Association therapy with macitentan added to sildenafil in a thalassemic patient with pulmonary hypertension
Michele Correale,Stefano Zicchino,Ilenia Monaco,Natale Daniele Brunetti,Matteo Di Biase
International Journal of Cardiology.2016;220(4)80
[DOI]
8A Novel Synthesis of Macitentan, an Endothelin Receptor Antagonist
Majid Nami,Sara Nasiri Sovari,Yaghoub Haghighatnia,Minoo Dabiri,Peyman Salehi
Organic Preparations and Procedures International.2017;49(3)258
[DOI]
9A focus on riociguat in the treatment of pulmonary arterial hypertension
Anne Kathrine Toxvig,Markus Wehland,Daniela Grimm,Manfred Infanger,Marcus Krüger
Basic & Clinical Pharmacology & Toxicology.2019;125(3)202
[DOI]
10The use of Macitentan in Fontan circulation: a case report
Polyvios Demetriades,Amir Aziz,Robin Condliffe,Sarah E. Bowater,Paul F. Clift
BMC Cardiovascular Disorders.2017;17(1)202
[DOI]
  Feedback 
  Subscribe